How to Diagnose Chronic Toxicity: A Step-by-Step TIE/TRE Workflow
- Apr 27
- 4 min read
Diagnosing the cause of chronic toxicity in wastewater can be one of the most challenging aspects of maintaining NPDES compliance in California. When a Whole Effluent Toxicity (WET) test fails, the next step is not just retesting, it is understanding why toxicity is occurring.
Regulatory guidance from the United States Environmental Protection Agency outlines a structured approach using:
Toxicity Reduction Evaluations (TREs)
Toxicity Identification Evaluations (TIEs)
Together, these provide a systematic framework to identify, isolate, and correct sources of toxicity.
Overview: TRE vs. TIE
Before diving into the workflow, it is important to understand the distinction:
Toxicity Reduction Evaluation (TRE):
A full investigation and corrective action process to eliminate toxicity
Toxicity Identification Evaluation (TIE):
A laboratory-based procedure used within a TRE to identify the class of toxicant
EPA guidance describes TREs as a stepwise process that includes investigation, identification, and implementation of control measures.
Step 1: Confirm the Chronic Toxicity
Before beginning a full investigation, confirm that toxicity is real and reproducible.
Key Actions:
Review QA/QC criteria (control survival, dilution water performance)
Verify sample handling and holding times
Conduct confirmatory WET testing if required
False positives can occur due to:
Sample contamination
Improper handling
Laboratory variability
Confirming the result prevents unnecessary investigation.
Step 2: Review Facility Operations and Recent Changes
Once toxicity is confirmed, the next step is to evaluate what has changed.
Evaluate:
Industrial or influent changes
New chemicals or suppliers
Treatment process upsets
Seasonal or stormwater impacts
EPA TRE guidance emphasizes that many toxicity events are linked to operational or influent variability, making this step critical.
Step 3: Evaluate Existing Chemical Data
Compare WET results with routine chemical monitoring data.
Focus on Known Toxicants:
Ammonia
Metals (copper, zinc, nickel)
Chlorine and oxidants
Organic compounds
Look for:
Correlations with toxicity events
Concentrations near known toxic thresholds
Trends over time
In some cases, the cause of toxicity can be identified without formal TIE testing.
Step 4: Initiate Phase I TIE (Characterization)
If the cause is not obvious, a Phase I TIE is conducted to characterize the type of toxicant.
Phase I TIE uses simple manipulations to determine general toxicant classes.
Common Phase I Treatments:
pH adjustment → indicates pH-dependent toxicants (e.g., ammonia, metals)
Filtration → identifies particulate-associated toxicity
Aeration → suggests volatile or oxidant toxicity
EDTA addition → indicates metals
Sodium thiosulfate → indicates oxidants (e.g., chlorine)
EPA TIE guidance describes these procedures as a way to narrow toxicity to broad categories.
Step 5: Interpret Phase I Results
Results from Phase I TIE provide direction for further investigation.
Example Interpretations:
Toxicity removed with EDTA → likely metals
Toxicity reduced with aeration → volatile compounds or oxidants
Toxicity affected by pH → ammonia or pH-dependent metals
At this stage, you are not identifying a specific compound—only the class of toxicant.
Step 6: Conduct Phase II TIE (Identification)
Phase II TIE focuses on identifying specific chemicals within the class identified in Phase I.
Methods May Include:
Chemical fractionation
Targeted analytical testing
Spiking studies (adding suspected toxicants)
For example:
If metals are suspected → analyze for copper, zinc, etc.
If ammonia is suspected → confirm with ammonia analysis and pH evaluation
Step 7: Confirm the Toxicant (Phase III TIE)
Phase III TIE confirms that the identified toxicant is responsible for the observed toxicity.
Common Approaches:
Remove the suspected toxicant and retest
Recreate toxicity by adding the toxicant back
Compare observed toxicity with expected toxicity
This step provides confidence that corrective actions will address the actual cause.
Step 8: Implement Toxicity Reduction Measures (TRE Phase)
Once the toxicant is identified, the focus shifts to reduction.
Common Strategies:
Source control: eliminate or reduce toxic inputs
Process optimization: improve treatment efficiency
Chemical substitution: replace problematic chemicals
Pretreatment enforcement: control industrial contributors
EPA TRE guidance emphasizes that solutions should be site-specific and practical.
Step 9: Monitor and Verify Compliance
After corrective actions are implemented:
Conduct follow-up WET testing
Track toxicity trends over time
Ensure consistent compliance with permit limits
If toxicity is resolved, TRE requirements may be concluded.
Common Pitfalls in Toxicity Diagnosis
Even with a structured workflow, several challenges can arise:
Multiple toxicants acting together
Intermittent toxicity events
Masking effects (one toxicant hiding another)
Changes in water chemistry during testing (e.g., pH drift)
These factors can complicate interpretation and require iterative testing
Key Takeaways
Diagnosing chronic toxicity requires a structured, step-by-step approach
TREs provide the overall framework, while TIEs identify the cause
Phase I–III TIE testing progressively narrows and confirms toxicants
Many toxicity issues are linked to common wastewater constituents
Early, systematic investigation significantly reduces time to resolution
References
United States Environmental Protection Agency (EPA).
Toxicity Reduction Evaluation (TRE) Guidance for Municipal Wastewater Treatment Plants (EPA/833B-99/002).
United States Environmental Protection Agency (EPA).
Methods for Aquatic Toxicity Identification Evaluations (TIE) – Phase I, II, III.
United States Environmental Protection Agency (EPA).
Short-Term Methods for Estimating the Chronic Toxicity of Effluents (EPA-821-R-02-013 & 014).
California State Water Resources Control Board.
NPDES Permit Program and Water Quality Control Policies.
California Environmental Laboratory Accreditation Program (ELAP).
Laboratory Accreditation and Testing Requirements.
Our Commitment
Our mission is to support California’s public agencies, utilities, and businesses by providing exceptional bioassay testing services that meet the highest scientific and regulatory standards.
Whether you’re preparing for a permit update, addressing toxicity concerns, or simply maintaining compliance, our team is here to help you stay ahead of the changing regulatory landscape.
For further details or support regarding California NPDES specifics, please contact us.
Comments